Literature DB >> 3910207

Experimental congenital syphilis in rabbits.

T J Fitzgerald.   

Abstract

A model for congenital syphilis in rabbits was developed based on multiple intravenous injections of pregnant does with high concentrations of Treponema pallidum. A total of 48 pregnant does and 394 newborns were evaluated. Indications of in utero infection included a 7- to 10-fold increase in fetal mortality and a 49% reduction in birth weight. The size of the stillborns varied. Some developed to normal size, whereas others were poorly developed, hemorrhagic, and 1/10th normal size. Fetuses were surgically removed after 25 to 28 days of gestation and extracts of the fetal tissues were injected into adult rabbits. Syphilitic lesions resulted demonstrating the presence of T. pallidum within the fetal tissues. Treponemes were also demonstrated within splenic tissue from a 1-week-old newborn. Isolated amniotic membranes were placed in Franz Biologic chambers. Viable organisms readily penetrated through the amnion but heat-inactivated organisms did not. Further evidence for in utero transmission of organisms was provided by intradermal injection of 6- to 7-week-old newborns. In control newborns in which the does were not infected during pregnancy, lesions occurred at 90% of the sites injected and developed in typical fashion. In newborns from does infected during pregnancy, lesions occurred in 18% of the sites injected and developed in atypical fashion (flat, nonulcerating, rapid healing). Finally, overt congenital syphilis did not occur if the does were immune prior to pregnancy, then infected with T. pallidum during pregnancy. The percent mortalities and birth weights of newborns were equivalent to control newborns from noninfected does.

Entities:  

Mesh:

Year:  1985        PMID: 3910207     DOI: 10.1139/m85-142

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  8 in total

1.  Experimental congenital syphilis: guinea pig model.

Authors:  K Wicher; R E Baughn; V Wicher; S Nakeeb
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

2.  Experimental model of congenital syphilis.

Authors:  A Kajdacsy-Balla; A Howeedy; O Bagasra
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

3.  Congenital syphilis in newborn rabbits: immune functions and susceptibility to challenge infection at 2 and 5 weeks of age.

Authors:  T J Fitzgerald; M K Froberg
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

4.  Pathology of congenital syphilis in rabbits.

Authors:  M K Froberg; T J Fitzgerald; T R Hamilton; B Hamilton; M Zarabi
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  The hyaluronidase associated with Treponema pallidum facilitates treponemal dissemination.

Authors:  T J Fitzgerald; L A Repesh
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

Review 6.  Rabbit Models for Studying Human Infectious Diseases.

Authors:  Xuwen Peng; John A Knouse; Krista M Hernon
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

7.  Current status of syphilis vaccine development: need, challenges, prospects.

Authors:  Caroline E Cameron; Sheila A Lukehart
Journal:  Vaccine       Date:  2013-10-14       Impact factor: 3.641

Review 8.  The wide utility of rabbits as models of human diseases.

Authors:  Pedro J Esteves; Joana Abrantes; Hanna-Mari Baldauf; Lbachir BenMohamed; Yuxing Chen; Neil Christensen; Javier González-Gallego; Lorenzo Giacani; Jiafen Hu; Gilla Kaplan; Oliver T Keppler; Katherine L Knight; Xiang-Peng Kong; Dennis K Lanning; Jacques Le Pendu; Ana Lemos de Matos; Jia Liu; Shuying Liu; Ana M Lopes; Shan Lu; Sheila Lukehart; Yukari C Manabe; Fabiana Neves; Grant McFadden; Ruimin Pan; Xuwen Peng; Patricia de Sousa-Pereira; Ana Pinheiro; Masmudur Rahman; Natalie Ruvoën-Clouet; Selvakumar Subbian; Maria Jesús Tuñón; Wessel van der Loo; Michael Vaine; Laura E Via; Shixia Wang; Rose Mage
Journal:  Exp Mol Med       Date:  2018-05-22       Impact factor: 8.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.